The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review

S Grazzini, C Rizzo, E Conticini, R D'Alessandro… - Autoimmunity …, 2023 - Elsevier
Idiopathic inflammatory myopathies (IIM) are a group of different conditions typically affecting
striate muscle, lung, joints, skin and gastrointestinal tract. Treatment typically relies on …

[PDF][PDF] Current concepts and advances in dermatomyositis: a dermatological perspective

D Lim, D Fiorentino, V Werth - Clin Exp Rheumatol, 2023 - clinexprheumatol.org
Dermatomyositis (DM) is an autoimmune disorder in which clinically amyopathic DM,
characterised by hallmark cutaneous findings in the absence of clinical weakness …

Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review

G La Rocca, F Ferro, C Baldini, A Libra… - Frontiers in …, 2023 - frontiersin.org
In recent decades, several pieces of evidence have drawn greater attention to the topic of
innate immunity, in particular, interferon (IFN) and Interleukin 6 in the pathogenesis of …

Promising Neutrophil‐Associated Biomarkers in Lung Diseases of Patients with Antisynthetase Syndrome and Dermatomyositis

L Liu, J Wang, P Zhang, W Sun, X Zhu… - Journal of …, 2022 - Wiley Online Library
Objectives. Antisynthetase syndrome (ASS) and dermatomyositis (DM) are serious
autoimmune diseases, with lungs being the most frequently involved organ and sometimes …

Emerging therapeutics in the management of connective tissue disease. Part II: Dermatomyositis and scleroderma

V Kodumudi, LA Bibb, JA Adalsteinsson… - Journal of the American …, 2022 - Elsevier
The management of connective tissue diseases is dramatically evolving with the advent of
biologics and novel oral systemic therapeutics. Despite involvement in the care of these …

Anasarca and spontaneous intramuscular haemmorhage in a dermatomyositis patient: case report and review of the literature

I Xynogalas, P Michail, G Katsikas, D Exarhos… - Clinical …, 2024 - Springer
Dermatomyositis is a rare, autoimmune systemic disorder of unknown aetiology that
presents as a constellation of clinical symptoms and signs primarily affecting skin and …

[PDF][PDF] Case study of tocilizumab in the treatment of dermatomyositis-associated interstitial lung disease

Z Wang, Z Zhang, C Sun - Frontiers in Medical Science …, 2024 - francis-press.com
Dermatomyositis (DM) complicated by rapidly progressive interstitial lung disease (RP-ILD)
is a type of connective tissue disease (CTD) with rapid disease progression and high …